Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Zynex Announces 2019 Second Quarter Earnings

      - Revenue increased 36% year over year to $10.3 million

      - Orders increased 65% year over year

      - Net income $2.2 million; Diluted EPS $0.06

      - Adjusted EBITDA $2.8M

      - Twelfth consecutive quarter of positive net income

      Zynex

      News provided by

      Zynex, Inc.

      Jul 31, 2019, 16:04 ET

      Share this article

      Share this article


      ENGLEWOOD, Colo., July 31, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2019.

      Second Quarter Financial Results Summary:
      For the second quarter, the Company reported net revenue of $10.3 million, a 36% increase over Q2-2018. Gross margins were 81% in the second quarter of 2019 and net income was $2.2 million.

      Adjusted EBITDA was $2.8 million in the second quarter of 2019 and 2018.

      The Company generated $2.4 million of cash from operations during the second quarter of 2019. As of June 30, 2019, the Company had working capital of $11.9 million compared to $7.3 million at December 31, 2018. Cash on hand was $10.1 million at the end of the second quarter.

      President and CEO Commentary:
      Thomas Sandgaard, CEO, said: "We followed our strong first quarter with continued growth in the second quarter with revenue of $10.3 million and net income of $2.2 million. Orders grew 65% compared to the second quarter of 2018 and were 48% higher year to date compared to the first half of 2018.

      In the second quarter, we continued to expand our sales force.  We expect the addition of new sales reps to have an impact on order and revenue growth this year and going forward.

      We continue to advocate for pain patients, and for physicians to prescribe our NexWave technology as the first line of defense in treating chronic and acute pain without side effects. We are dedicated to promoting our technology in an effort to remove patient addiction and other side effects from prescription opioids."

      Third Quarter 2019 Guidance:
      The estimate range for third quarter revenue is between $10.7 and $11.2 million with Adjusted EBITDA between $2.4 and $2.9 million as we continue to aggressively invest in growing our sales force. The revenue estimate is approximately 32% to 38% above last year's third quarter revenue of $8.1 million.

      Conference Call and Webcast Details:
      Wednesday, July 31, 2019 at 2:15 p.m. MT – 4:15 p.m. ET

      To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast:

      https://www.webcaster4.com/Webcast/Page/1487/31127 

      US PARTICIPANT DIAL IN (TOLL FREE):

      1-844-825-9790

      INTERNATIONAL DIAL IN:

      1-412-317-5170

      Canada Toll Free:

      1-855-669-9657

      Non-GAAP Financial Measures
      Zynex reports its financial results in accordance with accounting principles generally accepted in the U.S. (GAAP). In addition, the Company is providing in this news release financial information in the form of Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization, other income/expense and stock compensation). Management believes these non-GAAP financial measures are useful to investors and lenders in evaluating the overall financial health of the Company in that they allow for greater transparency of additional financial data routinely used by management to evaluate performance. Adjusted EBITDA can be useful for investors or lenders as an indicator of earnings available to service debt. Non-GAAP financial measures should not be considered in isolation from or as an alternative to the financial information prepared in accordance with GAAP.

      About Zynex 
      Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers.  For additional information, please visit: Zynex.com.

      Safe Harbor Statement
      Certain statements in this release are "forward-looking" or projections and as such are subject to numerous risks and uncertainties. The company makes no express or implied representation or warranty as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement for our products from health insurance companies, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force and other risks described in our filings with the Securities and Exchange Commission including the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2018 as well as Forms 10-Q, 8-K and 8-K/A, press releases and the Company's website.

      Contact:
      Zynex, Inc.
      (303) 703-4906

      Investor Relations Contact:
      Amato and Partners, LLC
      Investor Relations Counsel
      [email protected]

      ZYNEX, INC.

      CONSOLIDATED BALANCE SHEETS

      (AMOUNTS IN THOUSANDS)

      (unaudited)







      June 30,


      December 31,


      2019


      2018




      (as adjusted)

      ASSETS





      Current assets:





      Cash


      $             10,054


      $              10,128

      Accounts receivable, net


      3,540


      2,791

      Inventory, net


      1,325


      837

      Prepaid expenses and other


      833


      568

                                                     Total current assets


      15,752


      14,324






      Property and equipment, net


      822


      819

      Operating lease asset


      4,323


      3,050

      Financing lease asset


      9


      19

      Deposits


      342


      314

      Long term deferred income taxes


      591


      725

                                                     Total assets


      $             21,839


      $              19,251






      LIABILITIES AND STOCKHOLDERS' EQUITY





      Current liabilities:





      Accounts payable and accrued expenses


      1,829


      1,552

      Lease liability - operating leases


      965


      671

      Lease liability - financing leases


      14


      14

      Income taxes payable


      -


      688

      Dividends payable


      11


      2,270

      Accrued payroll and related taxes


      1,009


      908

      Deferred insurance reimbursement


      -


      880

                                                    Total current liabilities


      3,828


      6,983

      Long-term liabilities:





      Lease liability - operating leases


      3,940


      2,967

      Lease liability - financing leases


      4


      10

                                                    Total liabilities


      7,772


      9,960






      Stockholders' equity:





          Preferred stock


      -


      -

          Common stock


      34


      34

          Additional paid-in capital


      8,592


      8,157

          Treasury stock


      (3,846)


      (3,675)

          Accumulated earnings


      9,376


      4,864

                                                    Total Zynex, Inc. stockholders' equity


      14,156


      9,380

                                                    Non-controlling interest


      (89)


      (89)

                                                    Total stockholders' equity


      14,067


      9,291

                                                    Total liabilities and stockholders' equity


      $             21,839


      $              19,251

      ZYNEX, INC.

      CONSOLIDATED STATEMENTS OF OPERATIONS

      (in thousands, except per share data)

      (unaudited)













      For the Three Months Ended
      June 30,


      For the Six Months Ended
      June 30,




      2019


      2018


      2019


      2018


      NET REVENUE










      Devices


      $                      2,288


      $                      1,673


      $                      4,263


      $                      3,261


      Supplies


      8,009


      5,900


      15,230


      11,189


      Total net revenue


      10,297


      7,573


      19,493


      14,450












      COSTS OF REVENUE AND OPERATING EXPENSES










      Costs of revenue - rental, product & supply


      1,948


      1,330


      3,732


      2,566


      Sales and marketing


      3,081


      1,457


      5,554


      2,763


      General and administrative


      2,684


      2,071


      5,367


      4,450


      Total costs of revenue and operating expenses


      7,713


      4,858


      14,653


      9,779












      Income from operations


      2,584


      2,715


      4,840


      4,671












      Other income (expense)










         Deferred insurance reimbursement


      -


      -


      880


      -


         Interest expense


      -


      (37)


      -


      (153)


      Other income (expense), net


      -


      (37)


      880


      (153)












      Income from operations before income taxes


      2,584


      2,678


      5,720


      4,518


        Income tax expense


      422


      260


      1,208


      179


      Net Income


      $                      2,162


      $                      2,418


      $                      4,512


      $                      4,339












      Net income per share:










      Basic


      $                        0.07


      $                        0.07


      $                        0.14


      $                        0.13












      Diluted


      $                        0.06


      $                        0.07


      $                        0.13


      $                        0.13






















      Weighted average basic shares outstanding


      32,326


      32,620


      32,279


      32,610


      Weighted average diluted shares outstanding


      33,953


      34,169


      33,837


      34,291


      ZYNEX, INC.

      Reconciliation of GAAP to Non-GAAP Measures

      (in thousands)

      (unaudited)










      For the Three Months Ended June 30,


      For the Six Months Ended June 30,


      2019


      2018


      2019


      2018









      Net income

      $                            2,162


      $                            2,418


      $                            4,512


      $                            4,339

      Depreciation and Amortization

      76


      42


      142


      68

      Stock-based compensation expense

      158


      53


      297


      116

         Other (income)/expense, net

      -


      37


      (879)


      153

         Income tax expense (benefit)

      422


      260


      1,208


      179

      Adjusted EBITDA

      $                            2,818


      $                            2,810


      $                            5,280


      $                            4,855

      % of Net Revenue

      27%


      37%


      27%


      34%

       

      SOURCE Zynex, Inc.

      Modal title

      Also from this source

      Zynex Poised for New Future with Resolution of Federal Investigation

      Zynex Poised for New Future with Resolution of Federal Investigation

      Zynex, Inc., today announced that it has resolved the federal government's investigation into business practices designed and implemented by the...

      Zynex Announces New In-Network Provider Status with Humana

      Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Medical Equipment

      Medical Equipment

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.